Who Buys Temozolomide from India — 250 Importers Behind a $23.5M Market
India's temozolomide import market is served by 250 active buyers who collectively imported $23.5M across 1,261 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 19.9% market share, followed by TARO PHARMACEUTICALS INC., and TARO PHARMACEUTICALS INC. The top 5 buyers together control 53.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Temozolomide Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading temozolomide importer from India, holding a 19.9% share of the $23.5M market across 1,261 shipments from 250 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), TARO PHARMACEUTICALS INC., (CANADA), TARO PHARMACEUTICALS INC (CANADA), OOO"JODAS EXPOIM" (RUSSIA), M/S. SUN FARMACEUTICA DO BRAZIL LTD (BRAZIL) — collectively control 53.0% of total import value.
Top Temozolomide Buyers & Importers
Ranked by import value · 250 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM TEMOZOLOMIDE SUN CAP 100MG 1X5B HU PACKTEMOZOLOMIDE SUN CAP 250MG 1X5B HU PACKTEMOZOLOMIDE SUN CAP 140MG 4X5B DE PACK | $4.7M | 5 | 19.9% |
| 2 | TARO PHARMACEUTICALS INC.,CANADA TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5]TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH :TARO-TEMOZOLOMIDE 140 MG CAPSULE PACK :01*05 | $3.0M | 5 | 12.9% |
| 3 | TARO PHARMACEUTICALS INCCANADA TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5]TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH :TARO-TEMOZOLOMIDE 140 MG CAPSULE PACK :01*05 | $2.7M | 5 | 11.5% |
| 4 | OOO"JODAS EXPOIM"RUSSIA TEMOZOLOMIDE LYOPHILISATE FOR PREPARATIOTEMOZOLOMIDE CAPSULES 100MG NOSTEMOZOLOMIDE CAPSULES 100MG [TEMOMID] | $1.1M | 5 | 4.5% |
| 5 | M/S. SUN FARMACEUTICA DO BRAZIL LTDBRAZIL TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5]TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH :TARO-TEMOZOLOMIDE 140 MG CAPSULE PACK :01*05 | $980.0K | 5 | 4.2% |
| 6 | SUN FARMACEUTICA DO BRASIL LTDBRAZIL GLIOTEM 100 CAPSULESGLIOTEM 100 CAPSULES (TEMOZOLOMIDE CAPSUTEMOZOLOMIDE CAPSULES 180 MG | $763.8K | 5 | 3.2% |
| 7 | TARO PHARMACEUTICALS INC.CANADA TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5]TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH :TARO-TEMOZOLOMIDE 140 MG CAPSULE PACK :01*05 | $760.9K | 5 | 3.2% |
| 8 | YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAANBELGIUM TEMOZOLOMIDE SUN CAP 100MG 1X5B HU PACKTEMOZOLOMIDE SUN CAP 250MG 1X5B HU PACKTEMOZOLOMIDE SUN CAP 140MG 4X5B DE PACK | $536.7K | 5 | 2.3% |
| 9 | DEM PHARMACEUTICALSTURKEY TEMOZOLID 100 MG TEMOZOLOMIDE 100 MGTEMOZOLID 100 MG TEMOZOLOMIDE 100 MGNOSTEMOZOLOMIDE 100MG | $471.2K | 5 | 2.0% |
| 10 | OOOJODAS EXPOIMRUSSIA TEMOZOLOMIDE LYOPHILISATE FOR PREPARATIOTEMOZOLOMIDE CAPSULES 100MG NOSTEMOZOLOMIDE CAPSULES 100MG [TEMOMID] | $439.3K | 5 | 1.9% |
| 11 | LABORATORIOS LA SANTE S.A.COLOMBIA TEMITOMA 100MG CAPSULES [2986 PACK X 1X5]TEMITOMA 100MG CAPSULES [2880 PACK X 1X5]TEMITOMA 140 MG CAPSULES | $419.8K | 5 | 1.8% |
| 12 | SUN PHARMA PHILIPPINES INC.PHILIPPINES GLIOTEM 100 CAPSULESGLIOTEM 100 CAPSULES (TEMOZOLOMIDE CAPSUTEMOZOLOMIDE CAPSULES 180 MG | $404.5K | 5 | 1.7% |
| 13 | ACCORD HEALTHCARE B VNETHERLANDS | $343.6K | 5 | 1.5% |
| 14 | JAMP PHARMA CORPCANADA TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5]TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH :TARO-TEMOZOLOMIDE 140 MG CAPSULE PACK :01*05 | $321.0K | 5 | 1.4% |
| 15 | PHARMACENTER HUNGARY LTDHUNGARY | $255.7K | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Temozolomide — and from which countries?
Flow of Temozolomide exports from India: each country's share and the named importers behind the numbers
Temozolomide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Canada
Canada emerges as the first largest importing country, achieving a total trade value of $7.5M through 38 shipments. This represents a market share of 31.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• TARO PHARMACEUTICALS INC., - $3.0M (40.7% of country's total business)
• TARO PHARMACEUTICALS INC - $2.7M (36.1% of country's total business)
• TARO PHARMACEUTICALS INC. - $760.9K (10.2% of country's total business)
• JAMP PHARMA CORP - $321.0K (4.3% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $196.5K, indicating premium pricing strategy compared to the market average of $18.6K.
Canada is a key market for Temozolomide imports, representing 31.8% of total trade value.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $5.3M through 207 shipments. This represents a market share of 22.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $4.7M (88.3% of country's total business)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN - $536.7K (10.1% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $25.6K, indicating premium pricing strategy compared to the market average of $18.6K.
Belgium is a key market for Temozolomide imports, representing 22.5% of total trade value.
3Brazil
Brazil emerges as the third largest importing country, achieving a total trade value of $2.5M through 7 shipments. This represents a market share of 10.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• M/S. SUN FARMACEUTICA DO BRAZIL LTD - $980.0K (39.0% of country's total business)
• SUN FARMACEUTICA DO BRASIL LTD - $763.8K (30.4% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $359.1K, indicating premium pricing strategy compared to the market average of $18.6K.
Brazil is a key market for Temozolomide imports, representing 10.7% of total trade value.
4Russia
Russia emerges as the fourth largest importing country, achieving a total trade value of $1.7M through 13 shipments. This represents a market share of 7.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• OOO"JODAS EXPOIM" - $1.1M (63.9% of country's total business)
• OOOJODAS EXPOIM - $439.3K (26.4% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $127.8K, indicating premium pricing strategy compared to the market average of $18.6K.
Russia is a key market for Temozolomide imports, representing 7.1% of total trade value.
5United States
United States emerges as the fifth largest importing country, achieving a total trade value of $959.1K through 0 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: United States demonstrates strong market positioning with an average shipment value of $959.1K, indicating premium pricing strategy compared to the market average of $18.6K.
United States is a key market for Temozolomide imports, representing 4.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Temozolomide buyer market intelligence
1Buyer Segment Analysis
The importation of Temozolomide from India involves various buyer segments, each with distinct purchasing behaviors:
1. Distributors: Entities like Yusen Logistics Benelux Belgium and DEM Pharmaceuticals in Turkey function as intermediaries, procuring large quantities of Temozolomide for distribution to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to meet the demands of multiple clients.
2. Contract Manufacturers: Companies such as Taro Pharmaceuticals Inc. in Canada and OOO "Jodas Expoim" in Russia likely engage in contract manufacturing. They import Temozolomide to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement is typically consistent, aligning with production schedules and client contracts.
3. Re-exporters: Some buyers may act as re-exporters, importing Temozolomide from India to supply other markets. For instance, Yusen Logistics Benelux Belgium's significant import volumes suggest potential redistribution to neighboring European countries. This segment's purchasing behavior is influenced by regional demand fluctuations and trade agreements.
Understanding these segments is crucial for tailoring market strategies, ensuring supply chain efficiency, and meeting the specific needs of each buyer category.
Country-Specific Import Regulations
TransData Nexus Temozolomide buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Temozolomide vary across the top importing countries:
1. Canada:
2. Belgium:
3. Brazil:
4. Russia:
5. United States:
Importers should consult the respective regulatory authorities for the most current and detailed requirements.
Demand Drivers & Market Opportunity
TransData Nexus Temozolomide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Temozolomide is primarily driven by the prevalence of malignant gliomas, including glioblastoma multiforme and anaplastic astrocytoma. These aggressive brain tumors necessitate effective chemotherapy options, positioning Temozolomide as a critical treatment. The World Health Organization (WHO) includes Temozolomide in its Model List of Essential Medicines, underscoring its importance in global health. (cdn.who.int)
Government healthcare programs and the expansion of universal health coverage in various countries have enhanced access to essential medicines like Temozolomide. Over 150 countries have adopted national essential medicines lists based on the WHO Model List, facilitating procurement and supply. Tender-based purchasing mechanisms, often employed by national health services and international organizations, further streamline the acquisition process, ensuring consistent supply and affordability. (who.int)
With 250 buyers across 90 countries, the global market for Temozolomide reflects a widespread recognition of its therapeutic value and the concerted efforts to make it accessible to patients in need.
Common Questions — Temozolomide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest temozolomide buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $4.7M in imports and a 19.9% market share — the highest of any single temozolomide importer. TARO PHARMACEUTICALS INC., (CANADA) and TARO PHARMACEUTICALS INC (CANADA) are the next largest buyers.
QHow many companies buy temozolomide from India?
There are 250 active temozolomide buyers importing from India, with a combined market of $23.5M across 1,261 shipments to 90 countries. The top 5 buyers hold 53.0% of total import value, while the remaining 245 buyers handle the other 47.0%.
QWhich countries import the most temozolomide from India?
The top importing countries for temozolomide from India are Canada (31.8%), Belgium (22.5%), Brazil (10.7%), Russia (7.1%), United States (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of temozolomide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for temozolomide from India?
The average import transaction value for temozolomide from India is $18.6K, with an average unit price of $18.75 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Temozolomide buyer market intelligence
1Buyer Segment Analysis
The importation of Temozolomide from India involves various buyer segments, each with distinct purchasing behaviors:
1. Distributors: Entities like Yusen Logistics Benelux Belgium and DEM Pharmaceuticals in Turkey function as intermediaries, procuring large quantities of Temozolomide for distribution to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to meet the demands of multiple clients.
2. Contract Manufacturers: Companies such as Taro Pharmaceuticals Inc. in Canada and OOO "Jodas Expoim" in Russia likely engage in contract manufacturing. They import Temozolomide to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement is typically consistent, aligning with production schedules and client contracts.
3. Re-exporters: Some buyers may act as re-exporters, importing Temozolomide from India to supply other markets. For instance, Yusen Logistics Benelux Belgium's significant import volumes suggest potential redistribution to neighboring European countries. This segment's purchasing behavior is influenced by regional demand fluctuations and trade agreements.
Understanding these segments is crucial for tailoring market strategies, ensuring supply chain efficiency, and meeting the specific needs of each buyer category.
Country-Specific Import Regulations
TransData Nexus Temozolomide buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Temozolomide vary across the top importing countries:
1. Canada:
2. Belgium:
3. Brazil:
4. Russia:
5. United States:
Importers should consult the respective regulatory authorities for the most current and detailed requirements.
Demand Drivers & Market Opportunity
TransData Nexus Temozolomide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Temozolomide is primarily driven by the prevalence of malignant gliomas, including glioblastoma multiforme and anaplastic astrocytoma. These aggressive brain tumors necessitate effective chemotherapy options, positioning Temozolomide as a critical treatment. The World Health Organization (WHO) includes Temozolomide in its Model List of Essential Medicines, underscoring its importance in global health. (cdn.who.int)
Government healthcare programs and the expansion of universal health coverage in various countries have enhanced access to essential medicines like Temozolomide. Over 150 countries have adopted national essential medicines lists based on the WHO Model List, facilitating procurement and supply. Tender-based purchasing mechanisms, often employed by national health services and international organizations, further streamline the acquisition process, ensuring consistent supply and affordability. (who.int)
With 250 buyers across 90 countries, the global market for Temozolomide reflects a widespread recognition of its therapeutic value and the concerted efforts to make it accessible to patients in need.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 250 global importers of Temozolomide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,261 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 90 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,261 Verified Shipments
250 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists